GE Vernova Inc (GEV) Stock Price Today
Amer Sports posts Q3 EPS of $0.22, doubling estimates, with $1.63B revenue beating forecasts.
Amer Sports reported strong Q3 results with earnings per share of $0.22, doubling analyst expectations and up from $0.06 last year. Revenue reached $1.63 billion, surpassing the $1.54 billion consensus and showing significant growth from $1.24 billio...
Home Depot beats earnings and revenue estimates despite housing market challenges
Home Depot reported strong quarterly results with earnings per share of $4.92 and revenue of $47.86 billion, both surpassing analyst expectations. This growth comes amid a 'frozen housing market' where customers prefer smaller maintenance projects du...
Okta stock jumps on analyst upgrades and AI-driven growth optimism
Okta's stock surged following multiple analyst upgrades from firms like Jefferies, Wells Fargo, Citizens, and KeyBanc, who raised their price targets amid optimism about AI's indirect boost to Okta's identity management business. The company is outpe...
Santhera nears cash break-even as AGAMREE adoption grows in Europe
Santhera Pharmaceuticals is approaching cash flow break-even in Q3 2026, driven by strong uptake of its drug AGAMREE for Duchenne muscular dystrophy in Europe. AGAMREE, a corticosteroid with fewer side effects, has captured significant market share i...
Home Depot beats Q2 estimates with strong sales from smaller projects, shares rise 0.7%.
Home Depot reported second-quarter sales of $47.9 billion, beating analyst estimates due to strong demand for smaller home improvement projects. Adjusted earnings per share rose 5.1% to $4.92, surpassing expectations. Comparable sales increased 1.7%,...
US pending home sales drop 2.3% in July, signaling housing market struggles amid high mortgage rates.
The US pending home sales index fell 2.3% in July, missing expectations of a slight rise, as high mortgage rates and record home prices continue to deter buyers. Sales declined across all regions month-over-month, with year-over-year drops in most ar...
Shareholders of iTonic Holdings urged to join class action over alleged stock manipulation and misleading statements.
The Gross Law Firm has announced a class action lawsuit for shareholders of iTonic Holdings Ltd. (formerly Pheton Holdings Ltd.) who bought shares between September 5, 2024, and July 29, 2025. The lawsuit alleges the company and its affiliates engage...
Shareholders of Replimune Group urged to join class action over alleged misleading FDA data disclosures.
The Gross Law Firm has announced a class action lawsuit for shareholders of Replimune Group, Inc. who bought shares between October 20, 2025, and April 10, 2026. The lawsuit alleges that Replimune made false or misleading statements about its FDA Bio...
Kailera Therapeutics shares dip amid Phase 3 obesity drug trials and strategic partnership updates.
Kailera Therapeutics recently closed at $18.51, down 2.5% for the week and 28.8% since its April IPO. The clinical-stage company, with no product revenue, holds $1.17 billion in cash and has a runway into mid-2028. Its lead drug, ribupatide, is in gl...
Disney's ABC sues FCC over alleged retaliatory license review tied to political bias claims
Disney's ABC has filed a lawsuit against the Federal Communications Commission (FCC), accusing the Trump administration of retaliating against the network for its critical coverage by launching an early review of its broadcast licenses. The suit clai...
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.